The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes:

Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively).
Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease.
Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
Therapy in practice reviews covering optimum management of specific conditions.
Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine.
Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.

Editor (Adis International Limited, Auckland, New Zealand):
Amitabh Prakash
Consulting Editor:
A. Michael Lincoff, Cleveland Clinic Foundation, Cleveland, OH, USA
Editorial Board:
A. Barseghian El-Farra, University of California at Irvine, Irvine, CA, USA
B. Bhargava, All India Institute of Medical Sciences, New Delhi, India
D.L. Bhatt, Brigham and Women’s Hospital Heart & Vascular Center, Boston, MA, USA

P.C. Deedwania, University of California at San Francisco, Fresno, CA, USA

N.S. Dhalla, Institute of Cardiovascular Sciences, Winnipeg, MB, Canada 

P. Erwin, South Miami Heart Specialists, South Miami, FL, USA
A.M. Feldman, Temple University School of Medicine and Temple University Health System, Philadelphia, PA, USA

V. Fuster, Mount Sinai Medical Center, New York, NY, USA

X. Girerd, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

S. Goldstein, Henry Ford Heart and Vascular Institute, Detroit, MI, USA

J.A. Hill, UT Southwestern Medical Center, Dallas, TX, USA

G. Jagadeesh, Silver Spring, MD, USA

N.S. Kleiman, The Methodist DeBakey Heart Center , Houston, TX, USA

A. Lafont, Université Paris-Descartes, Paris, France

T.H. Le Jemtel, Tulane University Medical School, New Orleans, LA, USA
M. Marzilli, University of Pisa, Pisa, Italy

V. Menon, Cleveland Clinic, Cleveland, OH, USA
G. Montalescot, Pitié-Salpêtrière University Hospital, Paris, France

D. Morrone, University of Pisa, Pisa, Italy
S. Nicholls, Monash University, Melbourne, VIC, Australia
A. Oto, Hacettepe University School of Medicine, Ankara, Turkey

B. Pitt, University of Michigan Hospital, Ann Arbor, MI, USA

S. G. Priori, Fondazione Salvatore Maugeri, Pavia, Italy

C.V.S. Ram, Texas Blood Pressure Institute, Dallas, TX, USA

G. Reboldi, University of Perugia, Perugia, Italy
G. Santulli, Albert Einstein College of Medicine, New York, NY, USA
J. Silvain, Institut de Cardiologie, Paris, France
K.K. Talwar, Max Super Speciality Hospital, New Delhi, India

M. Tendera, Medical University of Silesia, Katowice, Poland
U. Thadani, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

A. Vahanian, Groupe Hospitalier Bichat-Claude Bernard, Paris, France

G.W. Vetrovec, Virginia Commonwealth University, Richmond, VA, USA

M.A. Weber, State University of New York, New York, NY, USA

W.S. Weintraub, MedStar Heart and Vascular Institute, Washington, DC, USA

H.D. White, Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
B.S. Wiggins, Medical University of South Carolina, Charleston, SC, USA
N.D. Wong, University of California at Irvine, Irvine, CA, USA